Cargando…
Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China
PURPOSE: This study aimed to analyse the genomic alteration profiles and immune characteristics of a cohort of Chinese cervical cancer patients to understand why certain patients benefited from molecular targeted therapies and immunotherapy as well as their prognostic significance. METHODS: PD-L1 ex...
Autores principales: | Liu, Jing, Li, Zirong, Lu, Ting, Pan, Junping, Li, Li, Song, Yanwen, Hu, Dan, Zhuo, Yanhong, Chen, Ying, Xu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636686/ https://www.ncbi.nlm.nih.gov/pubmed/36333792 http://dx.doi.org/10.1186/s12920-022-01376-9 |
Ejemplares similares
-
A Metastatic Cervical Adenocarcinoma Patient Carrying HER2 G292R Achieved Complete Response Upon Pyrotinib Treatment
por: Liu, Jing, et al.
Publicado: (2021) -
Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
por: Peng, Xinyi, et al.
Publicado: (2023) -
Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial
por: Xu, Qin, et al.
Publicado: (2022) -
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
por: Huo, Chen, et al.
Publicado: (2021) -
Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma
por: Yan, Hongmei, et al.
Publicado: (2020)